Oct 23 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* PYC THERAPEUTICS GETS FDA RESPONSE ON ORPHAN DRUG DESIGNATION REQUEST
* FDA SEEKS DATA ON CO'S LEAD DRUG VP-001
* DATA ASKED FOR DRUG'S USE IN ANIMAL MODEL OF RP/RETINAL DYSTROPHY DUE TO PRPF31 MUTATIONS OR IN PATIENTS BEFORE CONSIDERING REQUEST